6 results for author:"Roubelakis M." in Literature citations
Results Customize
› Repeat search in UniProtKB (4)
| Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Zoidakis J., Makridakis M., Zerefos P.G., Bitsika V., Esteban S., Frantzi M., Stravodimos K., Anagnou N.P., Roubelakis M.G., Sanchez-Carbayo M. et al. Mol. Cell Proteomics 11:M111.009449-M111.009449(2012) · Mapped (2) |
| OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Gazouli M., Roubelakis M.G., Theodoropoulos G.E., Papailiou J., Vaiopoulou A., Pappa K.I., Nikiteas N., Anagnou N.P. Mol. Carcinog. 51:165-173(2012) · Mapped (48) |
| Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms. Pappa K.I., Roubelakis M., Vlachos G., Marinopoulos S., Zissou A., Anagnou N.P., Antsaklis A. J. Matern. Fetal. Neonatal. Med. 24:628-635(2011) · Mapped (19) |
| The murine ortholog of the SHP-2 binding molecule, PZR accelerates cell migration on fibronectin and is expressed in early embryo formation. Roubelakis M.G., Martin-Rendon E., Tsaknakis G., Stavropoulos A., Watt S.M. J. Cell. Biochem. 102:955-969(2007) · Mapped (1) |
| Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Forde S., Tye B.J., Newey S.E., Roubelakis M., Smythe J., McGuckin C.P., Pettengell R., Watt S.M. |
| Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration. Zannettino A.C.W., Roubelakis M., Welldon K.J., Jackson D.E., Simmons P.J., Bendall L.J., Henniker A., Harrison K.L., Niutta S., Bradstock K.F. et al. Biochem. J. 370:537-549(2003) · UniProtKB (1) |